课题基金 / 基金详情

REcurrent VEnous thromboembolism Risk Stratification Evaluation (REVERSE): Long Term Follow-up to Define if Lifelong Anticoagulation is Required in High Risk Patients with a First Unprovoked Venous Thromboembolism

REcurrent VEnous thromboembolism Risk Stratification Evaluation (REVERSE): Long Term Follow-up to Define if Lifelong Anticoagulation is Required in High Risk Patients with a First Unprovoked Venous Thromboembolism
复发性静脉血栓栓塞风险分层评估 (REVERSE)：长期随访以确定首次无端静脉血栓栓塞的高危患者是否需要终身抗凝
批准号：
179363
负责人：
Rodger Marc A
金额：
$6.99万
依托单位：
Ottawa Hospital Research Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-09-01 至 2009-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=179363&lang=en
关键词：
High Risk Long-Term Outcomes Prospective Cohort Study Recurrent Venous Thromboembolism (Vte) Risk Stratification Unprovoked Venous Thromboembolism

项目摘要

项目成果

Rodger Marc A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Blood clots in leg veins (deep vein thrombosis) or lung arteries (pulmonary embolism) that arise without a clear cause (i.e. unexplained) are collectively called "unprovoked venous thromboembolism"(VTE). There is evidence that some of these patients with
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Safely Ruling out Deep Vein Thrombosis in Pregnancy with the LEFt Clinical Decision Rule and and D-dimer (the LEaD study): A Prospective Cohort Study
  • 批准号：
    344390
  • 项目类别：
    Operating Grants
  • 资助金额：
    $20.61万
  • 财政年份：
    2016
  • 负责人：
    Rodger Marc A
  • 依托单位：
    Ottawa Hospital Research Institute
Statins for Venous Event Reduction in patients with venous thromboembolism (The SAVER Pilot Randomized Trial)
  • 批准号：
    345461
  • 项目类别：
    Operating Grants
  • 资助金额：
    $30.91万
  • 财政年份：
    2016
  • 负责人：
    Rodger Marc A
  • 依托单位：
    Ottawa Hospital Research Institute
An individual patient data meta-analysis of low molecular weight heparin for prevention of placenta-mediated pregnancy complications
  • 批准号：
    269672
  • 项目类别：
    Operating Grants
  • 资助金额：
    $7.28万
  • 财政年份：
    2012
  • 负责人：
    Rodger Marc A
  • 依托单位：
    Ottawa Hospital Research Institute
A Pilot Study Assessing Feasibility of a Randomized, Placebo-controlled Trial of Low-Molecular-Weight-Heparin for Postpartum Prophylaxis in Women at Risk of Developing Venous Thromboembolism (pilot PROSPER Trial: PostpaRtum PrOphylaxiS for PE Randomized C
  • 批准号：
    202231
  • 项目类别：
    Operating Grants
  • 资助金额：
    $35.51万
  • 财政年份：
    2010
  • 负责人：
    Rodger Marc A
  • 依托单位：
    Ottawa Hospital Research Institute
海外基金